![]() |
|
|
Vol. 283, Issue 2, 750-756, 1997
Institute of Pharmacology, A pharmacological analysis was carried out in the rat urinary bladder
to assess the nature of muscarinic receptors subtypes functionally
involved in the negative feedback mechanism regulating acetylcholine
(ACh) secretion from postganglionic cholinergic nerve terminals and in
smooth muscle contraction. Bladder strips were preincubated with
3H-choline, and the electrically evoked
[3H]ACh release was detected simultaneously with
contraction in the absence of acetylcholinesterase inhibitors. The
effects were compared of seven muscarinic antagonists on
[3H]ACh secretion (prejunctional effect) and muscle
contraction (postjunctional effect). The rank order of postjunctional
potencies (
log EC50) for the seven antagonists
(atropine > 4-diphenylacetoxy-N-methylpiperidine methiodide
(4-DAMP) > hexahydrosiladiphenidol hydrochloride (HHSiD) > tripitramine > pirenzepine > AF DX-116 > methoctramine) as well as their postjunctional affinity estimates
(pA2) are in keeping with the notion that
muscarinic receptors responsible for bladder contraction belong to the
M3 subtype. The M3 subtype-preferring 4-DAMP
and HHSiD did not discriminate between prejunctional and postjunctional
effects. The M2/M4 subtype-preferring
antagonists tripitramine, methoctramine and AF-DX 116 were more potent
in facilitating the evoked [3H]ACh release than in
inhibiting the contractile response. The rank order of prejunctional
potencies was atropine > 4-DAMP > tripitramine > HHSiD > methoctramine > AF-DX 116 > pirenzepine, indicating the involvement of M4 receptors. Furthermore,
when potency relationship was determined by correlating
prejunctional
log EC50 values with published constants for
cloned and natives muscarinic receptor subtypes, the correlations were
significant for both M4 and M5 subtypes, but
the best correlation found (P < .001) was for the M4
subtype. These findings suggest that the negative feedback mechanism
inhibiting the release of ACh in the rat urinary bladder is mediated by
prejunctional autoreceptors of the M4 subtype.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
K.-E. Andersson and A. J. Wein Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence Pharmacol. Rev., December 1, 2004; 56(4): 581 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pontari, A. S. Braverman, and M. R. Ruggieri Sr. The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R874 - R880. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Douglas, H. A. Baghdoyan, and R. Lydic M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in Prefrontal Cortex of C57BL/6J Mouse J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 960 - 966. [Abstract] [Full Text] [PDF] |
||||